These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19480095)

  • 21. 2011 drug packaging review: too many dangers and too many patients overlooked.
    Prescrire Int; 2012 May; 21(127):133-4, 136-8. PubMed ID: 22827008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic evaluation of rifabutin in combination with lopinavir-ritonavir in patients with HIV infection and active tuberculosis.
    Boulanger C; Hollender E; Farrell K; Stambaugh JJ; Maasen D; Ashkin D; Symes S; Espinoza LA; Rivero RO; Graham JJ; Peloquin CA
    Clin Infect Dis; 2009 Nov; 49(9):1305-11. PubMed ID: 19807276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Water-soluble prodrugs of the human immunodeficiency virus protease inhibitors lopinavir and ritonavir.
    DeGoey DA; Grampovnik DJ; Flosi WJ; Marsh KC; Wang XC; Klein LL; McDaniel KF; Liu Y; Long MA; Kati WM; Molla A; Kempf DJ
    J Med Chem; 2009 May; 52(9):2964-70. PubMed ID: 19348416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Injectable morphine: more room for improvement.
    Prescrire Int; 2006 Feb; 15(81):16-7. PubMed ID: 16548107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rebuilding regulation after the Mediator disaster: drug regulatory agencies must tackle the issue of packaging.
    Prescrire Int; 2012 May; 21(127):137. PubMed ID: 22827010
    [No Abstract]   [Full Text] [Related]  

  • 26. ISMP Medication Errors.
    Shastay A
    Home Healthc Now; 2015 May; 33(5):282-3. PubMed ID: 25943222
    [No Abstract]   [Full Text] [Related]  

  • 27. Failure of treatment with first-line lopinavir boosted with ritonavir can be explained by novel resistance pathways with protease mutation 76V.
    Nijhuis M; Wensing AM; Bierman WF; de Jong D; Kagan R; Fun A; Jaspers CA; Schurink KA; van Agtmael MA; Boucher CA
    J Infect Dis; 2009 Sep; 200(5):698-709. PubMed ID: 19627247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic interactions between rifabutin and lopinavir/ritonavir in HIV-infected patients with mycobacterial co-infection.
    Khachi H; O'Connell R; Ladenheim D; Orkin C
    J Antimicrob Chemother; 2009 Oct; 64(4):871-3. PubMed ID: 19628472
    [No Abstract]   [Full Text] [Related]  

  • 29. Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).
    Negredo E; Miró O; Rodríguez-Santiago B; Garrabou G; Estany C; Masabeu A; Force L; Barrufet P; Cucurull J; Domingo P; Alonso-Villaverde C; Bonjoch A; Morén C; Pérez-Alvarez N; Clotet B;
    Clin Infect Dis; 2009 Sep; 49(6):892-900. PubMed ID: 19663689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Injection syringes and dosage corks in the administration of peroral fluid drugs].
    Hedgard I
    Lakartidningen; 1980 Jul; 77(30-31):2623-4. PubMed ID: 7442375
    [No Abstract]   [Full Text] [Related]  

  • 31. Medication errors associated with packaging and labeling of i.v. bags.
    Health Devices; 1997 Nov; 26(11):440-2. PubMed ID: 9360171
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug packaging: improvements needed to protect children.
    Prescrire Int; 2012 May; 21(127):135. PubMed ID: 22827009
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparison of semitransparent colored labels with opaque colored labels for prevention of adverse drug administration].
    Suzuki H; Tomita Y; Eguchi H; Takeuchi K; Fukuda S
    Masui; 2005 May; 54(5):563-7. PubMed ID: 15915760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Confusing drug packaging contributes to death of 15 children.
    Pakenham-Walsh N; Ana J
    Lancet Glob Health; 2014 Nov; 2(11):e634. PubMed ID: 25442687
    [No Abstract]   [Full Text] [Related]  

  • 35. [Drug vial labeling and medication errors in anaesthesia: do these features break up?].
    Debaene B
    Ann Fr Anesth Reanim; 2012 Jan; 31(1):4-5. PubMed ID: 22154440
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug packaging in 2013: small changes would reap big benefits.
    Prescrire Int; 2014 May; 23(149):136-8. PubMed ID: 24926522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fosamprenavir/ritonavir in advanced HIV disease (TRIAD): a randomized study of high-dose, dual-boosted or standard dose fosamprenavir/ritonavir in HIV-1-infected patients with antiretroviral resistance.
    Molina JM; Ait-Khaled M; Rinaldi R; Penco G; Baril JG; Cauda R; Soriano V; Pialoux G; Wire MB; Lou Y; Givens N; Craig C; Nichols WG; Barbosa I; Yeo J;
    J Antimicrob Chemother; 2009 Aug; 64(2):398-410. PubMed ID: 19515730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug mix-ups].
    Nielsen RH; Hellebek A
    Ugeskr Laeger; 2009 Mar; 171(10):811-4. PubMed ID: 19265609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Near misses with prefilled syringes.
    Patel BV; Holland C; Pook J
    Br J Anaesth; 2006 Feb; 96(2):270. PubMed ID: 16415325
    [No Abstract]   [Full Text] [Related]  

  • 40. Epinephrine. Tragic overdose.
    Cohen M
    Nursing; 1996 Apr; 26(4):13. PubMed ID: 8710262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.